Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells

Molecular Immunology

Volumn 59, Issue 1, 2014, Pages 10-18

  Schaper, Katrin ^a   Kietzmann, Manfred ^a   Bäumer, Wolfgang ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Dendritic cells; IL 12; IL 23; IL 27; MAPK; Sphingosine 1 phosphate

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; FINGOLIMOD; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 27; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; SPHINGOSINE 1 PHOSPHATE; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; KERATINOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

DENDRITIC CELLS; IL-12; IL-23; IL-27; MAPK; SPHINGOSINE-1-PHOSPHATE;

ANDROSTADIENES; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; DENDRITIC CELLS; ENZYME INHIBITORS; GENE EXPRESSION; IMMUNOBLOTTING; INTERLEUKIN-12; INTERLEUKIN-23; INTERLEUKIN-27; LIPOPOLYSACCHARIDES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; OXADIAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PYRAZOLES; PYRIDINES; RECEPTORS, LYSOSPHINGOLIPID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPHINGOSINE; THIOPHENES;

EID: 84892460651     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2013.11.015     Document Type: Article

References (49)

1. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278:1910-1914.
2. Anliker B., Chun J. Lysophospholipid G protein-coupled receptors. J. Biol. Chem. 2004, 279:20555-20558.
3. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., Kuchroo V.K., Oukka M., Weiner H.L. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
5. Bäumer W., Kietzmann M. Effects of cyclosporin A and cilomilast on activated canine, murine and human keratinocytes. Vet. Dermatol. 2007, 18:107-114.
6. Blot V., Jaquemard U., Reissig H.U., Kleuser B. Practical sythesis of sphingosine-1-phosphate and analogues. Sythesis-Stuttgart 2009, 759-766.
7. Bowcock A.M., Krueger J.G. Getting under the skin: the immunogenetics of psoriasis. Nat. Rev. Immunol. 2005, 5:699-711.
8. Brereton C.F., Sutton C.E., Lalor S.J., Lavelle E.C., Mills K.H. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease. J. Immunol. 2009, 183:1715-1723.
9. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol. Therapeut. 2007, 115:84-105.
10. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S., Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996, 381:800-803.
11. Davis M.D., Kehrl J.H. The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function. Immunol. Res. 2009, 43:187-197.
12. Duvallet E., Semerano L., Assier E., Falgarone G., Boissier M.C. Interleukin-23: a key cytokine in inflammatory diseases. Ann. Med. 2011, 43:503-511.
13. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
14. Hayashi F., Yanagawa Y., Onoe K., Iwabuchi K. Dendritic cell differentiation with prostaglandin E results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production. Immunology 2010, 131:67-76.
15. Hughes J.E., Srinivasan S., Lynch K.R., Proia R.L., Ferdek P., Hedrick C.C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ. Res. 2008, 102:950-958.
16. Idzko M., Panther E., Corinti S., Morelli A., Ferrari D., Herouy Y., Dichmann S., Mockenhaupt M., Gebicke-Haerter P., Di Virgilio F., Girolomoni G., Norgauer J. Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses. FASEB J. 2002, 16:625-627.
17. Jackson A.M., Mulcahy L.A., Porte J., Franks H.A., El Refaee M., Wang Q., Shah S., Zhu X., Patel P.M. Role of mitogen-activated protein kinase and PI3K pathways in the regulation of IL-12-family cytokines in dendritic cells and the generation of T H-responses. Eur. Cytokine Netw. 2010, 21:319-328.
18. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., Braun D., Banerjee S. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 2012, 366:1190-1199.
19. Li Y., Chu N., Hu A., Gran B., Rostami A., Zhang G.X. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp. Mol. Pathol. 2008, 84:1-8.
20. Lowes M.A., Kikuchi T., Fuentes-Duculan J., Cardinale I., Zaba L.C., Haider A.S., Bowman E.P., Krueger J.G. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 2008, 128:1207-1211.
21. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
22. Martino A., Volpe E., Auricchio G., Izzi V., Poccia F., Mariani F., Colizzi V., Baldini P.M. Sphingosine 1-phosphate interferes on the differentiation of human monocytes into competent dendritic cells. Scand. J. Immunol. 2007, 65:84-91.
23. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., Allende M.L., Proia R.L., Cyster J.G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360.
24. Meyer zu Heringdorf D., Lass H., Kuchar I., Alemany R., Guo Y., Schmidt M., Jakobs K.H. Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor. FEBS Lett. 1999, 461:217-222.
25. Mitchell D., Yong M., Schroder W., Black M., Tirrell M., Olive C. Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. J. Infect. Dis. 2010, 202:318-329.
26. Muller H., Hofer S., Kaneider N., Neuwirt H., Mosheimer B., Mayer G., Konwalinka G., Heufler C., Tiefenthaler M. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol. 2005, 35:533-545.
27. Mullershausen F., Zecri F., Cetin C., Billich A., Guerini D., Seuwen K. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat. Chem. Biol. 2009, 5:428-434.
28. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. N. Engl. J. Med. 2009, 361:496-509.
29. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13:715-725.
30. Piskin G., Sylva-Steenland R.M., Bos J.D., Teunissen M.B. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 2006, 176:1908-1915.
31. Rathinasamy A., Czeloth N., Pabst O., Forster R., Bernhardt G. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J. Immunol. 2010, 185:4072-4081.
32. Reines I., Kietzmann M., Mischke R., Tschernig T., Luth A., Kleuser B., Baumer W. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. J. Invest. Dermatol. 2009, 129:1954-1962.
33. Renkl A., Berod L., Mockenhaupt M., Idzko M., Panther E., Termeer C., Elsner P., Huber M., Norgauer J. Distinct effects of sphingosine-1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int. J. Mol. Med. 2004, 13:203-209.
34. Sanna M.G., Liao J., Jo E., Alfonso C., Ahn M.Y., Peterson M.S., Webb B., Lefebvre S., Chun J., Gray N., Rosen H. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 2004, 279:13839-13848.
35. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
36. Schaper K., Dickhaut J., Japtok L., Kietzmann M., Mischke R., Kleuser B., Baumer W. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J. Dermatol. Sci. 2013, 71:29-36.
37. Schroder M., Richter C., Juan M.H., Maltusch K., Giegold O., Quintini G., Pfeilschifter J.M., Huwiler A., Radeke H.H. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. Mol. Immunol. 2011, 48:1139-1148.
38. Schuppel M., Kurschner U., Kleuser U., Schafer-Korting M., Kleuser B. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype. J. Invest. Dermatol. 2008, 128:1747-1756.
39. Schwab S.R., Cyster J.G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 2007, 8:1295-1301.
40. Shibata S., Tada Y., Kanda N., Nashiro K., Kamata M., Karakawa M., Miyagaki T., Kai H., Saeki H., Shirakata Y., Watanabe S., Tamaki K., Sato S. Possible roles of IL-27 in the pathogenesis of psoriasis. J. Invest. Dermatol. 2010, 130:1034-1039.
41. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 2003, 4:397-407.
42. Steinman L. A rush to judgment on Th17. J. Exp. Med. 2008, 205:1517-1522.
43. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., Villarino A.V., Huang Q., Yoshimura A., Sehy D., Saris C.J., O'Shea J.J., Hennighausen L., Ernst M., Hunter C.A. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006, 7:937-945.
44. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., Yoshimura A., Yoshida H. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003, 170:4886-4890.
45. Trinchieri G., Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res. Immunol. 1995, 146:423-431.
46. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
47. Wittmann M., Kienlin P., Mommert S., Kapp A., Werfel T. Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway. J. Immunol. 2002, 168:3793-3800.
48. Xu M., Mizoguchi I., Morishima N., Chiba Y., Mizuguchi J., Yoshimoto T. Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin. Dev. Immunol. 2010, 2010. pii: 832454. 10.1155/2010/832454.
49. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.